News
Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
August 2021
Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19 vaccine, which it hopes to have in production within 18 months.
Digital subscribers to The Australian can read more here.
News
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
News
September 2021 Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust...
News
November 2018 Australian biotechnology firm Sementis has entered into a research and development (R&D) partnership...